Please login to the form below

Not currently logged in
Email:
Password:

EU

This page shows the latest EU news and features for those working in and with pharma, biotech and healthcare.

AZ raises full-year guidance after completing Alexion acquisition in Q2

AZ raises full-year guidance after completing Alexion acquisition in Q2

This includes the company’s complement component 5 (C5) inhibitors Soliris (eculizumab) and Ultomiris (ravulizumab), which are already available in the US and EU.

Latest news

More from news
Approximately 138 fully matching, plus 2,249 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 9 fully matching, plus 201 partially matching documents found.

Latest appointments

More from appointments
Approximately 2 fully matching, plus 67 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 3 fully matching, plus 129 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Branding Science

We are Branding Science Partners in thinking which inspires change in healthcare Branding Science are an award-winning global pharmaceutical market...

Latest intelligence

Guide
How to embrace behavioural science principles in healthcare MR...
Top 10 ways to leverage the Impetus InSite Platform® to (virtually) launch your brand
The Impetus InSite Platform® can be used to facilitate virtual and hybrid engagement at all stages of the product lifecycle. Here, we share 10 of the most popular ways to...
Employee wellbeing in creative agencies: three tips to get you started
Paul Hutchings, founder of fox&cat, and new friend, Welfy, a workplace wellbeing training firm, discuss the importance of collaboration...